Oligonucleotides
Abcam SR-8278, REV-ERBalpha antagonist, 25MG
MW 361.5 Da. REV-ERBα antagonist (EC₅₀ = 470 nM, REV-ERBα transcriptional repression activity). Stimulates the expression of gluconeogenesis genes G6Pase and PEPCK.
The product is subject to the following: Abcam Restricted Use Statement
Abcam T0901317, L x R agonist, 10MG
MW 481.3 Da, Purity >99%. Potent, non-selective LXR agonist (EC₅₀ = 50 nM). Increases ABCA1 expression associated with cholesterol efflux regulation and HDL metabolism. Increases muscle expression of PPAR-δ. Shows antiobesogenic effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam SAM e (S-(5-Adenosyl)-L-methionine disulfate tosylate), Methyl donor, 50MG
MW 763.8 Da, Purity >95%. Methyl donor and cofactor for enzyme-catalyzed methylations, such as catechol O-methyltransferase (COMT) and DNA methyltransferases (DNMT).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Spectinomycin hydrochloride pentahydrate, aminocylcitol antibiotic, 1G
MW 368.81 Da, Purity >98%. An aminocyclcitol antibiotic. Active against Gram-positive and Gram-negative bacteria. Binds the 30S ribosome subunit and interrupts protein synthesis by interfering with peptidyl tRNA translocation.
The product is subject to the following: Abcam Restricted Use Statement
Abcam alpha-NETA, Fluorescent ChAT inhibitor, 5MG
MW 369.24 Da. alpha-NETA, Fluorescent ChAT inhibitor. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Fludarabine (FAMP), DNA synthesis inhibitor, 50MG
MW 285.23 Da, Purity >98%. DNA synthesis inhibitor. Prodrug converted to active metabolite F-ara-A which inhibits ribonucleotide reductase and competitively inhibits DNA polymerase. Also prevents DNA ligase I from joining DNA. Induces apoptosis. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
